Syndax Pharmaceuticals Inc (SNDX)
15.60
-0.35
(-2.19%)
USD |
NASDAQ |
Nov 21, 16:00
15.59
-0.01
(-0.06%)
After-Hours: 20:00
Syndax Pharmaceuticals Profit Margin (Quarterly): -673.0% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -673.0% |
| June 30, 2024 | -1.94K% |
| March 31, 2024 | |
| December 31, 2023 | |
| September 30, 2023 | |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | |
| September 30, 2022 | |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 76.00% |
| September 30, 2021 | -166.8% |
| June 30, 2021 | -6.04K% |
| March 31, 2021 | -7.31K% |
| December 31, 2020 | -5.39K% |
| September 30, 2020 | -5.39K% |
| June 30, 2020 | -4.50K% |
| March 31, 2020 | -4.02K% |
| Date | Value |
|---|---|
| December 31, 2019 | -3.69K% |
| September 30, 2019 | -3.38K% |
| June 30, 2019 | -3.94K% |
| March 31, 2019 | -3.77K% |
| December 31, 2018 | -4.97K% |
| September 30, 2018 | -4.57K% |
| June 30, 2018 | -4.85K% |
| March 31, 2018 | -5.12K% |
| December 31, 2017 | -1.60K% |
| September 30, 2017 | -4.95K% |
| June 30, 2017 | -4.47K% |
| March 31, 2017 | -4.25K% |
| December 31, 2016 | -3.55K% |
| September 30, 2016 | -4.91K% |
| June 30, 2016 | -2.74K% |
| March 31, 2016 | -3.39K% |
| December 31, 2015 | -1.73K% |
| September 30, 2015 | -2.53K% |
| June 30, 2015 | -36.55K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-7.31K%
Minimum
Mar 2021
76.00%
Maximum
Dec 2021
-3.55K%
Average
-4.02K%
Median
Mar 2020
Profit Margin (Quarterly) Benchmarks
| Vertex Pharmaceuticals Inc | 37.71% |
| Moderna Inc | 0.70% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -67.33% |
| Return on Assets | -60.43% |
| Return on Invested Capital | -67.33% |
| Operating Margin (Quarterly) | -716.6% |
| Return on Net Operating Assets | -3.04K% |